Patients Reimagining VLU and DFU management: Why speed matters in chr... Chronic wounds, particularly venous leg ulcers (VLUs) and diabetic foot ulcers (DFUs), represent a persistent and growing challenge in healthcare.
News ESC26: Can Arrowhead pierce Ionis' triglyceride armour? Arrowhead Pharma is squaring up to rival Ionis in the severe hypertriglyceridaemia (sHTG) market, drawing on phase 3 data at ESC 2026.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.